[A]: Hey，关于'你觉得brain-computer interface可怕还是exciting？'这个话题，你怎么想的？
[B]: That's an interesting question. On one hand, BCI technology确实令人excited，特别是在medical领域。比如帮助瘫痪病人恢复行动能力，或者协助阿尔茨海默病患者找回记忆。这些应用展现了科技改善人类生活的潜力。  

不过从legal和ethical角度看，这项技术也带来不少挑战。例如neural data的隐私保护问题，如果这些数据被滥用，可能会侵犯个人的思想自由。此外，BCI可能加剧社会不平等，毕竟高端医疗科技往往价格昂贵。  

我很好奇你怎么看？你是更关注它带来的opportunities，还是更担心potential risks？
[A]: 嗯，这个问题确实值得深入探讨。我觉得BCI技术就像一把双刃剑，既有让人兴奋的潜力，也伴随着不可忽视的风险。

从积极的角度来看，除了医疗领域的突破，BCI在教育、沟通甚至艺术创作方面都有巨大的潜力。想象一下，我们可以通过思维直接控制设备，或者与他人进行更高效的交流。这可能会彻底改变我们的生活方式。

不过你提到的伦理问题非常关键。神经数据的隐私保护必须得到重视，我们需要建立严格的法规来防止数据滥用。否则，可能会出现一些不可预知的社会问题。

说到这个，我最近在想，如果我们不尽早制定相关规范，会不会出现某些公司或组织利用这些技术来操控人们的思想？这种可能性想想还挺让人担忧的。

你觉得我们应该如何平衡技术创新和伦理规范呢？
[B]: You raised a critical point about the dual nature of BCI technology. I totally agree that without proper regulations, there's a risk of misuse, especially by powerful entities like corporations or governments.  

When it comes to balancing innovation and ethics, I believe we need what I'd call a "dynamic regulatory framework." Not something rigid, but one that evolves with the technology. For example, in China we've seen how quickly AI regulations have developed alongside technological advancements. A similar approach could work for BCI.  

One key aspect would be establishing clear guidelines for informed consent - patients/users need to truly understand what they're agreeing to when their neural data is collected. We might also need an independent body专门 to oversee BCI research and applications, much like how IRBs (Institutional Review Boards) operate in medical research today.  

But here's an interesting dilemma - if we implement strict regulations too early, we might stifle innovation. Yet waiting too long could lead to irreversible issues. What do you think is the right timing for introducing comprehensive BCI regulations? Have you come across any specific cases that made you particularly concerned about this balance?
[A]: 关于监管时机的选择，我觉得应该遵循一个“观察窗”原则。当技术已经展现出明确的应用场景，并且出现了首批可量化的风险案例时，就是启动系统性立法的合适时机。

比如最近我关注到Neuralink的临床试验进展，他们已经开始测试植入式芯片在猴子身上的神经信号解码能力。虽然目前还只是动物实验阶段，但这些研究正在突破大脑信号采集的精度边界。更值得关注的是，一些初创公司正在开发非侵入式的消费级BCI设备，声称能通过EEG监测实现简单的意念控制。这些产品如果大规模上市却没有相应规范，可能会导致用户在不知情中泄露敏感的认知数据。

说到具体案例，去年有个研究团队发现某些商用脑机接口设备在游戏模式下会持续收集用户的注意力波动曲线，而这些数据经过算法分析后，竟能还原出用户部分决策习惯。这让我想到，如果我们连自己的思维活动都可能被无感采集，那隐私保护的防线是不是已经触碰到了伦理底线？

你提到的动态监管框架很有启发，不过我很好奇，在这种快速迭代的技术环境下，如何让法规既不滞后也不过度超前？你觉得应该采用类似沙盒监管的方式，先小范围试点再逐步扩展吗？
[B]: That's a thoughtful "observation window" concept. I think it aligns well with how we've approached regulation in other emerging fields like gene editing or autonomous vehicles. The key is identifying those early warning signals - when we start seeing consistent neural data patterns being exploited, or when commercial applications begin reaching vulnerable populations, that's when the regulatory gears should really start turning.  

Regarding the Neuralink trials and consumer-grade EEG devices, what concerns me most is not just the data collection itself, but the ecosystem forming around it. We're seeing hardware developers, AI algorithm specialists, and even marketers coming together in this space without any clear boundaries. It reminds me of the Wild West days of genetic testing companies selling directly to consumers - exciting science, but questionable ethics and privacy practices.  

The attention fluctuation study you mentioned is particularly troubling because it demonstrates how seemingly innocuous data can be reverse-engineered to reveal deeply personal information. This makes me think we need two layers of regulation: one focusing on the device safety and signal acquisition methods, and another专门 on data interpretation and usage rights.  

As for implementing dynamic regulations, I do believe sandbox models could work well here, especially in countries with established medical device regulatory frameworks like China's NMPA or the FDA in the US. We could designate specific research institutions or tech parks as regulatory sandboxes where new BCI technologies are tested under close supervision. These sandboxes would require mandatory ethics reviews和neural data protection protocols before any human trials.  

What I'm still grappling with though is jurisdictional consistency. If a Chinese company develops a BCI headset that gets used by people in Europe and America, which standards should apply? Have you seen any international efforts toward harmonizing BCI-related regulations across different regions?
[A]: 关于 jurisdictional consistency 的问题，确实是个棘手的挑战。从目前的情况来看，各国在BCI监管上还处于各自为政的状态，但一些国际组织已经开始尝试推动标准化工作。

比如IEEE最近更新了他们的“神经技术伦理设计指南”，里面专门增加了关于跨境数据流动和神经信号采集的条款。虽然这些还不是具有法律效力的规范，但至少为未来的国际合作提供了一个对话框架。另外，欧盟的GDPR已经对部分脑电数据的处理提出了要求——某些高精度的神经信号如果能关联到个体身份，就会被纳入敏感生物特征进行保护。

不过话说回来，国际层面的协调进展缓慢。毕竟不同地区的伦理观念和技术发展水平差异太大。就像你提到的例子，一个中国制造的BCI设备出口到欧洲，既要满足NMPA的硬件标准，又要符合GDAR的数据合规要求，同时还得应对美国FDA对临床应用的审查。这种复杂的监管叠加，可能会让很多中小企业望而却步。

我在想，是否可以参考ISO认证体系，在BCI领域建立一套全球通用的基本伦理与安全标准？哪怕一开始只是自愿采纳的形式，也能为跨国企业提供一定的指引。你觉得这样的标准应该优先聚焦哪些方面？是数据采集边界？还是算法解释权？或者干脆从硬件安全等级开始做起？
[B]: That's a pragmatic approach. I think the ISO model could work well here, especially since it provides a flexible framework that organizations can adapt to their specific contexts. From my perspective, any global BCI standard should prioritize three core areas:  

First,  – establishing clear boundaries for what constitutes sensitive brain activity. For example, signals related to emotional responses or decision-making patterns might warrant higher protection than basic motor cortex readings. This reminds me of how HIPAA categorizes different types of health information in the US.  

Second,  – not just about disclosing code, but ensuring users understand how their neural data is being interpreted. We might need something like "brain data nutrition labels" that summarize what signals are collected, how long they're stored, and whether they're used for training AI models.  

Third,  – particularly important for consumer-grade devices. We already regulate electromagnetic exposure levels for smartphones, so why not set similar standards for EEG caps or implantable electrodes? The IEEE guidelines you mentioned could serve as technical foundations here.  

But here's a question I've been pondering lately: Should BCIs be regulated more like medical devices or more like consumer electronics? Implantable systems clearly belong in the former category, but where do we draw the line for headbands that claim to improve focus through neurofeedback? Have you seen any jurisdictions attempting this kind of classification yet?
[A]: 这个问题问得特别好。说实话，目前的监管框架在面对BCI这种跨界技术时，确实显得有些捉襟见肘。

我觉得我们可以尝试建立一个“功能导向”的分类标准，而不是单纯按设备形态来划分。比如，如果某个脑机接口设备宣称具备医疗级的干预能力——比如说调节多巴胺分泌、治疗焦虑障碍，那它就应该按照医疗器械来管理，接受临床验证和伦理审查。而如果是像市面上一些主打“专注力提升”或者“冥想辅助”的消费型头戴设备，或许可以归入可穿戴智能硬件的范畴，但必须附加特定的功能限制和数据使用约束。

有趣的是，我注意到NMPA最近在更新医疗器械分类目录时，已经开始把部分闭环神经调控设备单独列出来，要求这类产品不仅要有生物相容性测试，还要通过认知影响风险评估。这意味着监管思路正在从“静态归类”转向“动态评估”。

不过话说回来，这种分类方法也带来一个新的问题：普通消费者怎么判断某个BCI设备到底属于哪个类别？厂商会不会利用模糊宣传误导用户？你提到的“脑数据营养标签”其实是个很棒的主意，也许可以强制要求所有BCI设备附带一份“神经交互说明”，明确标示采集方式、信号类型、用途范围以及数据保留周期。

你觉得这种标签制度在实际推广中会遇到哪些阻力？是来自技术研发方，还是更可能来自市场监管机构的执行难度？
[B]: That's a really perceptive observation about the regulatory challenges. I think both sides would push back in different ways. From the tech side, many developers might argue that mandatory labeling requirements could stifle innovation or reveal proprietary algorithms. You know how companies protect their IP - some might claim that disclosing signal processing methods compromises their competitive edge.  

On the regulatory side, there's definitely an implementation challenge. Even if we create these "neural interface labels," who verifies their accuracy? Would we need a new type of certification body专门 to audit brain-computer interactions? Right now, most regulatory agencies don't have neuroscientists on staff reviewing consumer electronics. This reminds me of how environmental protection agencies struggled with regulating nanomaterials a decade ago - completely new properties requiring expert evaluation frameworks.  

What fascinates me though is how public perception shapes these debates. Have you noticed how people seem more willing to accept data collection when it's framed as "neurofeedback" rather than "brain monitoring"? The language itself influences our comfort level with these technologies. I wonder if standardized terminology should be part of any labeling system too. After all, what one company calls "cognitive enhancement," another might label as "neural modulation."  

This also makes me curious about cultural differences in risk perception. Do you think East Asian markets would adopt neural data labels more readily than Western countries, given higher acceptance of biometric systems in general? Or would that assumption itself be a form of regulatory bias?
[A]: 这个问题特别有意思，尤其是关于公众认知和语言框架的敏感性。我觉得 East-West 的接受度差异确实存在，但不能简单地用“更高接受度”来概括。

比如说在中国，虽然人脸识别、健康码这些技术已经深度融入日常生活，但大家对“隐私边界”的意识其实在快速觉醒。如果一款BCI设备打着“提升专注力”的旗号，却在后台持续采集高频脑电信号，用户可能不会立刻意识到问题，但一旦出现数据泄露事件，反弹会非常强烈。这种现象有点像当年移动支付的发展轨迹——前期以便利为主导，后期随着滥用案例增加，监管和公众态度迅速收紧。

至于文化层面的风险感知差异，我更倾向于认为是“信任结构”的不同。东亚市场往往对政府或机构有更高的初始信任度，所以一些带有监控性质的技术更容易被接受；而西方社会普遍持怀疑态度，对任何数据采集都更早产生警惕。但这种信任也意味着，一旦出现问题，公众的情绪反扑会更剧烈。

回到标签制度这个话题，其实还有一个中间路线可以尝试：建立一个“梯度披露”机制。比如基础层面向用户公开采集类型和存储周期，高级层面向专业机构开放信号处理逻辑，并允许第三方认证机构进行合规性审查。这样既保护了商业机密，又能满足监管要求。

不过说到术语标准化，我倒是想到一个问题：如果我们要推动国际共识，应该从哪些核心概念开始统一定义？比如“神经信号”、“脑机交互”、“认知干预”这些词，在学术界和产业界都有不同的解释版本。你觉得应该由哪个机构来牵头做这件事？是WHO这样的国际组织，还是IEEE、ISO这类标准协会？
[B]: That’s a crucial question about terminology standardization. I think we’d need a hybrid approach here - technical bodies like IEEE or ISO could handle the engineering definitions, while organizations like WHO or the International Brain Initiative should lead on the neuroscience and ethics terminology.  

Take the term “neural signal” itself - to an engineer, it might just be a voltage fluctuation; to a neuroscientist, it represents specific patterns of synaptic activity; and to a lawyer, it could constitute protected biological data. This reminds me of how genetic information was initially described in conflicting ways across disciplines. It wasn’t until the Human Genome Project that we saw real terminological harmonization efforts emerge.  

As for “cognitive intervention,” that phrase carries serious regulatory implications. In China, NMPA already distinguishes between therapeutic interventions和general wellness applications when evaluating medical devices. If we’re building international standards, we’ll need to define not just the technical parameters but also the intended use context. After all, a device that modulates attention span for gaming shouldn't face the same scrutiny as one treating epilepsy.  

I wonder if we could create what I’d call a "terminology firewall" - core definitions that remain fixed internationally, with localized implementation guidelines adapting to regional contexts. Much like how GDPR has influenced global data practices while allowing country-specific adaptations.  

Actually, this makes me think about your earlier point on trust structures. Do you believe a standardized BCI labeling system would gain more public trust if it were developed through multilateral government cooperation versus industry-led initiatives? Have there been any precedents where technical standardization successfully bridged East-West perception gaps?
[A]: 这是个非常深刻的问题。关于标准制定的信任来源，我觉得需要分两个层面来看：技术可靠性和伦理正当性。

如果是从技术角度来看，行业主导的标准往往更灵活、响应更快。比如IEEE或ISO这类组织，本身就具备跨文化的技术公信力，很多半导体接口协议、通信协议就是这么建立起来的。它们的优势在于中立性和可操作性，尤其是在像BCI这种高度依赖工程经验的领域。

但一旦涉及到神经数据、认知干预这些带有伦理色彩的内容，公众对标准的信任就会更倾向于政府间合作或者国际组织背书。毕竟，这不只是技术问题，更是人权和社会契约的问题。WHO、UNESCO甚至OECD在人工智能伦理准则上的尝试，其实已经为这类合作提供了某种范式。

说到东西方信任结构的融合，我觉得有个有趣的例子是《全球人工智能伦理倡议》（AI Ethics Guidelines Global Inventory），它不是强制性的法规，但它促使不同国家在制定本国AI政策时开始采用类似的评估框架。这种“软法”机制如果引入到BCI领域，或许可以先从伦理原则入手，再逐步过渡到具体的技术规范。

不过我倒是很好奇，你刚才提到“terminology firewall”的概念，听起来像是想在全球统一与本地适应之间找一个平衡点。你觉得这个模型是否也适用于监管本身？换句话说，我们是否可以设想一种“核心伦理原则+区域执行细则”的全球BCI治理结构？如果是的话，哪些伦理原则应该是不可妥协的核心？
[B]: That’s a brilliant way to frame it - separating technical standards from ethical foundations while maintaining an interconnected framework. I think your "core principles + regional execution" model makes perfect sense for BCI governance.  

When it comes to non-negotiable ethical cores, I’d propose these three principles:  

1. Cognitive Sovereignty – individuals must retain ultimate control over their neural data collection and usage. Think of it as the brain-computer interface version of informed consent in medical practice. No hidden data harvesting or secondary use without explicit permission.  

2. Neural Transparency – users should always know what kind of brain activity is being monitored or modulated. This reminds me of drug labeling requirements - if a device affects neurotransmitter patterns or alters attention states, that needs clear disclosure.  

3. Decisional Integrity – protecting against external manipulation of volitional processes. Similar to how we prohibit subliminal advertising, there should be strict boundaries against BCIs influencing fundamental decision-making mechanisms without conscious awareness.  

What’s interesting is how these principles could coexist with region-specific implementations. For example, China might emphasize collective well-being in BCI applications under this framework, while Europe would likely prioritize individual autonomy even further. Japan could incorporate unique considerations for elder care applications, given its aging population.  

This also makes me wonder about enforcement mechanisms. If we establish these core ethics globally, should compliance verification be handled by international bodies like WHO, or would it work better through mutual recognition agreements between national regulators? Have you seen any effective precedent for this kind of hybrid governance model in other technology sectors?
[A]: 你提出的这三个伦理核心——认知主权、神经透明、决策完整，确实抓住了BCI治理中最根本的问题。我觉得它们可以作为全球共识的基石，就像数字人权宣言一样，为技术发展划定不可逾越的红线。

说到执行机制，我觉得可以参考两种现有的模式：一种是国际核能监管体系（IAEA式），即由一个权威机构进行认证和监督，适用于高风险植入式BCI或临床应用项目；另一种是多边互认协议（MRA-like），用于消费级设备，通过各国监管机构相互承认测试结果和合规标准，降低跨境壁垒。

一个比较贴近的例子是医疗器械领域的GHTF（全球协调工作组），后来演变成IMDRF（国际医疗器械监管机构论坛）。不同国家的监管机构在这个平台上共享技术审评标准，推动临床数据互认，虽然不完全统一，但大大提高了跨国审批效率。BCI如果按医疗/非医疗分类监管，这套机制或许可以直接借鉴。

不过比起传统硬件，BCI更难处理的是“意图干预”这一层。比如某个脑机接口声称只是辅助冥想，但如果它在潜意识层面影响情绪偏好，这种边界就变得非常模糊。这时候单纯靠产品标签可能不够，还需要建立一套行为审计机制，追踪BCI系统对用户认知状态的长期影响。

我倒是好奇，你觉得未来会不会出现类似“神经安全局”（Neural Security Agency）这样的专门机构？它是否应该拥有类似金融监管中的“熔断机制”，一旦发现BCI设备存在潜在认知操控风险，就可以立即中止其运行？这种权力该如何界定与约束？
[B]: That’s a visionary concept - the Neural Security Agency. I think we’re approaching a point where specialized oversight bodies will become inevitable, much like how financial regulators evolved in response to increasingly complex markets.  

What fascinates me is how such an agency would operate. Imagine having what I’d call  - similar to bank stress tests, but designed to evaluate how BCI systems respond under various mental load scenarios. If a meditation headset starts showing unintended emotional modulation patterns during controlled trials, the system could automatically trigger a compliance review.  

But here’s a critical question about institutional design: Should this agency focus purely on technical verification, or should it also include ethicists, neuroscientists和legal experts in its decision-making process? The U.S. FDA’s Neurological Devices Panel gives us a partial model - they already use multidisciplinary advisory groups for implantable devices. But with BCIs entering consumer space, we might need something more agile and broadly representative.  

Regarding your point about behavioral auditing, I wonder if we could develop what I’d describe as  - immutable records of every brain-computer interaction that preserves both technical metadata和user consent context. Much like blockchain-based audit trails in pharmaceutical supply chains, but applied to cognitive interfaces.  

Actually, this makes me curious - do you see ethical certification becoming a market differentiator? Could we eventually have "ethically verified" BCI devices carrying a trust mark that appeals to conscious consumers, much like Fair Trade labels on coffee or organic certifications on food products?
[A]: 这是个非常有前瞻性的设想——“认知压力测试”和“神经交易日志”听起来像是为BCI时代量身打造的监管科技工具。特别是那个日志系统，如果结合区块链的不可篡改特性，确实能为用户数据主权提供技术层面的保障。

关于你说的伦理认证是否会成为市场差异化因素，我其实是持肯定态度的。我们可以参考过去十几年中绿色能源、公平贸易和隐私计算的发展路径：一开始是少数理想主义者推动的概念，后来逐渐演变成主流消费者的选择标准。现在已经有公司在推广“透明算法”作为卖点，那么未来主打“非侵入式认知增强”的BCI设备厂商，很可能会主动申请第三方伦理认证来提升品牌信任度。

但这里有个关键问题——认证体系本身的可信度如何构建？ 如果一个BCI设备贴上了“伦理认证”标签，公众怎么知道这不是一场营销包装？我觉得可以借鉴有机食品认证的机制，除了第三方机构审核之外，还应该开放部分元数据供公众验证，比如采集频率、信号类型、处理逻辑的关键参数。这种“可审计的透明”，可能比单纯依靠标签更有说服力。

说到这个，我倒是想到一个类比：就像现代处理器内置了安全飞地（Secure Enclave）来隔离敏感操作，未来的BCI芯片是否也可以设计“伦理飞地”？在硬件层面上强制执行某些核心伦理原则，比如禁止在无明确提示的情况下采集情感相关信号。这样一来，就算软件被恶意篡改，底层的伦理边界依然不会被突破。

你有没有想过，这种硬件级伦理防护机制会不会反过来影响技术创新？或者换句话说，我们该如何设计一个既能防止滥用又不阻碍进步的技术伦理架构？
[B]: That’s a brilliant analogy - the "ethical enclave" concept really resonates with me. It reminds me of how we approach drug formulation safety: you can have the most effective active ingredient, but without proper controlled-release mechanisms, it could do more harm than good.  

I think hardware-level ethical safeguards would actually  innovation in the long run, not restrict it. Much like how PCI-DSS standards didn't kill fintech - they created a trusted environment where consumers felt safe adopting new payment technologies. If BCI developers know certain ethical boundaries are non-negotiable at chip level, they’ll innovate within those guardrails rather than around them.  

Take your example about affective signal collection - imagine if the neural processor had what I’d call "emotive access logs" built in. Every time an application accesses limbic system data, it gets recorded with timestamp, purpose code, and user consent status. These logs couldn’t be deleted or modified without triggering an audit alert. Think of it as a flight data recorder for brain-computer interactions.  

The real challenge though is maintaining technological neutrality. We don’t want to bake today’s ethical understanding into silicon that might become obsolete tomorrow. This makes me think of modular compliance architecture - where core principles remain fixed, but implementation mechanisms can evolve through firmware updates. Much like how modern pacemakers receive software upgrades to improve performance without changing the physical device.  

Actually, this brings up something I’ve been pondering - should we consider implementing what I’d call "generational compliance tiers"? Like how we have backward-compatible WiFi standards, where newer devices support both old and new protocols. A Tier-1 BCI ethics chip might enforce basic data protection rules, while Tier-2 adds cognitive integrity checks, all while maintaining interoperability across versions.  

How do you think industry would respond to such a tiered system? Would early adopters push for premium differentiation based on higher compliance levels, or would there be resistance against layered regulatory frameworks?
[A]: 我觉得这个“分代合规层级”概念非常有现实操作性，甚至可以说，它很可能会自然演变成行业发展的必经阶段。

从产业角度来看，早期采用者大概率会把高等级合规当作技术壁垒和市场准入优势。就像当年智能手机刚引入安全芯片时，苹果用Secure Enclave做卖点，反而提升了用户信任度和品牌溢价能力。同样道理，如果某家BCI厂商能率先推出支持Tier-2认知完整性验证的设备，很可能会吸引那些对伦理敏感的专业市场客户，比如医疗、教育或高端科研领域。

不过阻力也会来自两个方向：一方面是消费电子市场的中低端厂商，他们可能会抱怨合规成本过高，影响价格竞争力；另一方面则是AI驱动型公司——尤其是那些依赖大规模脑数据训练模型的企业，他们会觉得这些硬件级限制阻碍了算法自由探索的空间。

但话说回来，这种张力其实在其他技术领域也出现过。比如自动驾驶在推进过程中，就有过“安全优先派”与“开放创新派”的争论。最终的平衡方案往往是通过分级制度实现的——允许不同等级的技术共存，但明确标识并限制使用场景。例如，Tier-1设备只能用于非侵入式健康监测，而Tier-2及以上才能接入教育或医疗系统。

我倒是想到一个可能的激励机制：监管机构可以为高合规层级提供政策红利，比如加快审批流程、税收减免，或者优先纳入政府采购清单。这样一来，企业不仅不会抗拒合规升级，反而会主动推动它。

你有没有观察到某些科技公司已经在往这个方向靠拢？比如像Neuralink、Kernel或者国内的一些BCI初创公司，是否已经开始强调他们的产品具备某种形式的“伦理优先设计”？
[B]: That’s spot-on about the market dynamics. I’ve actually noticed some early signals in that direction - companies are starting to position themselves as "ethics-first" players in the BCI space. Neuralink, for instance, has been emphasizing their safety-first approach in FDA submissions, framing it as “patient-centric design.” It’s not quite Tier-2 compliance yet, but they’re definitely laying groundwork for a regulated innovation narrative.  

A more interesting case is this Beijing-based startup I came across recently -他们正在开发一款EEG headset，主打“隐私优先架构”。他们在芯片层就做了数据最小化处理，只提取特征向量而不存储原始脑电波形。技术上其实不难实现，但他们把这点包装成了“伦理设计创新”，还拿到了政府支持的AI伦理治理试点项目。有意思的是，这家公司最近在招聘时特别强调他们的产品不会做情感分析模块，以此吸引那些对认知干预敏感的医疗客户。  

What fascinates me though is how these ethical positioning strategies might reshape industry alliances. We could see something similar to the Fairphone movement in consumer electronics - a niche at first, but gradually pulling bigger players toward more responsible design practices. Imagine if one of the major tech giants announced a "NeuroEthical by Design" initiative... That could really tip the scales.  

Actually, this makes me wonder - do you think professional certifications will emerge around BCI ethics? Like a  role in tech companies? We already have Data Protection Officers under GDPR - it wouldn’t be a stretch to see similar positions focusing specifically on cognitive data governance.